Background illustration for clinical trials search

Paid Clinical Trials Idaho

Discover 289 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 289

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for

Lymphoma, Large B-Cell, Diffuse

Location: Boston MA, Westbury NY, Mineola NY, New York NY,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

for

COVID-19 Infection

Location: Boston MA, Worcester MA, Teaneck NJ, Baltimore MD,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07013474

Phase3, Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

for

Type 1 Diabetes Mellitus, T1D, T1DM,

Location: Boston MA, New York NY, Baltimore MD, Greenville NC,

Sponsor: COUR Pharmaceutical Development Company, Inc.

Sex: All

Age: 12 - 35

Code: NCT06783309

Phase1, Phase2, Recruiting

Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers Living in Idaho

for

Maternal Stress

Location: Coeur d'Alene ID, Moscow ID

Sponsor: University of Idaho

Sex: Female

Age: 18 - 64

Code: NCT06919718

Recruiting

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

for

Head and Neck Squamous Cell Carcinoma,

Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06992427

Phase3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for

Advanced Malignant Solid Neoplasm,

Location: Brewer ME, Augusta ME, Scarborough ME,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase2, Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for

Metastatic Salivary Gland Carcinoma,

Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase2, Recruiting

The Fourth Left Atrial Appendage Occlusion Study

for

Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism

Location: Providence RI, Burlington MA, Quebec, Sherbrooke,

Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia,

Location: Halifax, Portland ME, Scarborough ME, South Portland ME,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

PREVENT ALL ALS Study

for

Amyotrophic Lateral Sclerosis

Location: Boston MA, New Britain CT, Lebanon NH, New York NY,

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Sex: All

Age: 18+

Code: NCT06581861

Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

for

Focal Epilepsy

Location: New Haven CT, Stony Brook NY, Woodmere NY, Hawthorne NY,

Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06132893

Phase2, Phase3, Recruiting

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

for

Hodgkin Lymphoma, Non-Hodgkin Lymphoma

Location: The Bronx NY, Long Branch NJ, Summit NJ, Pompton NJ,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT06002828

Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,

Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for

Biochemically Recurrent Prostate Carcinoma,

Location: Stony Brook NY, Bay Shore NY, Lake Success NY,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for

Cardiotoxicity, HER2/Neu Positive,

Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Halifax, Portland ME, Scarborough ME, South Portland ME,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for

Triple Negative Breast Cancer

Location: Scarborough ME, South Weymouth MA, Boston MA,

Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

for

Migraine

Location: The Bronx NY, Washington D.C. DC, Tamarac FL,

Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT05156398

Phase3, Recruiting

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

for

Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea,

Location: Chicago IL, Minneapolis MN, Spokane WA, Boise ID,

Sponsor: Seattle Institute for Biomedical and Clinical Research

Sex: All

Age: 18+

Code: NCT06390345

Recruiting

Effectiveness of Aurix Therapy in Venous Leg Ulcers

for

Venous Leg Ulcers

Location: Boston MA, Bristol CT, Middletown NY, Harris NY,

Sponsor: Nuo Therapeutics

Sex: All

Age: 18+

Code: NCT02352454

Recruiting

Popular cities in Idaho

Idaho Falls Meridian Boise

Paid Clinical Trials Idaho

Filter results

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers Living in Idaho

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Interested in new trials?

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

The Fourth Left Atrial Appendage Occlusion Study

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

PREVENT ALL ALS Study

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Effectiveness of Aurix Therapy in Venous Leg Ulcers

Popular cities in Idaho